Cancer has been the leading cause of death in Idaho since 2008, exacting an enormous burden on residents of our state. There were 7,605 cases of invasive cancer and 2,789 cancer deaths among Idaho?s 1.63 million residents in 2014. Idaho has among the lowest cancer screening rates in the country, in 2014 ranking 44th among states and the District of Columbia for colorectal cancer screening, 50th for mammography, and 51st for cervical cancer screening. Poverty and race/ethnicity contribute to increased late-stage diagnosis of several cancers and disparities in incidence rates. The Idaho Hospital Association (IHA) is very pleased to submit this application for the National Program of Cancer Registries (NPCR) component of CDC-RFA-DP17-1701, Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations, for the project, Cancer Data Registry of Idaho (CDRI). CDRI, a program of the IHA, is a population-based cancer registry collecting incidence and survival data on all cancer patients who reside in Idaho and out-of-state residents diagnosed or treated for cancer in Idaho. CDRI has been population-based since 1971 and has statutory authority under Idaho Code 57-1703 through 57-1707. IHA is considered the state?s bona fide agent for the NPCR component of CDC-RFA-DP17-1701. CDRI is recognized by CDC as an NPCR Registry of Excellence, indicating we meet National Data Quality and Advanced National Data Quality standards. CDRI successfully carried out work funded by the previous DP12-1205 award and looks forward to building upon that body of work to reduce cancer morbidity and mortality and reducing health disparities under DP17-1701.The purpose of this application is to be able to continue operating CDRI as an efficient, high-quality population-based cancer registry capable of ongoing collection and dissemination and improved and enhanced electronic reporting of complete, accurate, and timely data on all Idaho reportable cancer cas
es to advise public health cancer prevention and control. CDRI?s project is designed to support overarching long-term outcomes of reducing cancer risk, increasing health behaviors, increasing quality of life among cancer survivors, reducing cancer morbidity and mortality, and reducing cancer disparities. CDRI has developed a proposed work plan consistent with Cancer Prevention and Control Programs for State, Territorial and Tribal Organizations and National Program of Cancer Registries logic models and NPCR Program Standards to achieve outcomes through the application of multiple strategies, including program collaboration, external partnerships, cancer data and surveillance, community level interventions and patient support, health systems change, and program monitoring and evaluation. CDRI will use a myriad of evaluation and performance measurement tools to measure progress towards achieving objectives and continuous program improvement of timeliness, quality, and completeness of data; electronic case capture; dissemination of analysis and reports; and effective collaborations. CDRI pledges full support and active participation with partners in the Idaho comprehensive cancer control and breast and cervical cancer early detection programs and has received an outpouring of support for our application from these and external partners. Members of CDRI?s Advisory Committee are committed to promoting data use, coordinating and collaborating with cancer prevention and control and other chronic disease programs, and refining quality improvement initiatives. CDRI is a highly qualified cancer registry with expertise in collecting population-based central cancer registry data and reporting on population-based incidence, treatment, and survival data and with the capability and expertise to contribute to CDC?s Division of Cancer Prevention and Control in meeting mission goals and the capacity to implement the approach described in our application.
